Press-release for stocks publishing date 2022 - 02

Prices are updated after-hours

publishing date : 2022 - 02 - 15 tags : Als

save search

Jazz Pharmaceuticals to Report 2021 Fourth Quarter and Full Year Financial Results on March 1, 2022
Published: 2022-02-15 (Crawled : 23:00) - biospace.com/
JAZZ | $109.685 0.79% 0.78% 380K

Health Technology

| -23.53% | O: 0.08% H: 2.83% C: 1.44%
als financial results report results

Commercial Metals Company Announces Completion of Redemption of 2027 Notes
Published: 2022-02-15 (Crawled : 22:00) - prnewswire.com
CMC | $54.45 -1.18% 0.0% 850K

Non-Energy Minerals

| 49.24% | O: -0.6% H: 2.15% C: 0.71%
als commercialization redemptions

[Amend] Statement of acquisition of beneficial ownership by individuals
Published: 2022-02-15 (Crawled : 20:00) - teekay.com
TNK | $56.47 0.36% 0.29% 200K

Transportation

| 404.66% | O: -0.81% H: 1.45% C: 1.36%
TK | $7.28 0.83% 0.0% 370K

Transportation

| 132.15% | O: -0.64% H: 1.29% C: 0.32%
als acquisition state

Compass Minerals Presents the Big 12 Basketball Food Drive
Published: 2022-02-15 (Crawled : 18:00) - compassminerals.com
PSX | News | $158.84 1.14% 0.0% 1.8M

Energy Minerals

| 73.5% | O: -2.07% H: 1.03% C: -0.26%
als food

USD 90.38 Million Growth in Water Treatment Chemicals Market in Australia | Evolving Opportunities with Accepta Ltd. And Albemarle Corp. | 17,000+ Technavio Reports
Published: 2022-02-15 (Crawled : 17:00) - prnewswire.com
ECL | News | $219.66 0.16% 0.0% 720K

Process Industries

| 19.9% | O: -0.24% H: 2.0% C: 0.42%
DOW | $56.74 -0.44% 0.0% 3.1M

Process Industries

| -6.31% | O: -0.02% H: 1.96% C: 1.71%
treatment ema als australia report growth

Citius Pharmaceuticals Announces FDA Acceptance of IND Application for its Phase 2b Study of Halo-Lido for the Prescription Treatment of Hemorrhoids
Published: 2022-02-15 (Crawled : 15:30) - biospace.com/
CTXR | $0.772 5.15% 4.9% 670K

Health Technology

| -52.6% | O: 0.65% H: 7.1% C: 5.16%
treatment fda phase 2 als hemorrhoids application phase 2b fda acceptance

Aqua Metals on Track to Deploy AquaRefining in Future Lithium-Ion Battery Recycling Operation
Published: 2022-02-15 (Crawled : 14:30) - globenewswire.com
AQMS | $0.518 5.93% 5.6% 250K

Non-Energy Minerals

| -47.68% | O: -0.72% H: 20.44% C: 19.37%
battery als lithium

NRx Pharmaceuticals Announces US National Institutes of Health Study of ZYESAMI® (aviptadil) in Critical COVID-19 is Cleared to Complete Full Enrollment
Published: 2022-02-15 (Crawled : 14:00) - prnewswire.com
NRXP | $3.1 3.33% 3.23% 110K

Manufacturing

| -0.33% | O: 1.66% H: 9.15% C: -0.65%
GILD | $67.03 0.12% 0.12% 5.2M

Health Technology

| 9.56% | O: 0.01% H: 0.65% C: 0.35%
covid-19 zyesami aviptadil health als covid yes enroll

Aquinnah Pharmaceuticals Announces Collaboration with Roche to Advance New Therapies for ALS and Other Neurodegenerative Diseases
Published: 2022-02-15 (Crawled : 14:00) - biospace.com/
PFE | News 4 | $26.32 0.23% 0.0% 24M

Health Technology

| -47.27% | O: 0.0% H: 0.48% C: -0.02%
als announces collaboration disease neurodegenerative collaboration therapy

TG Therapeutics Announces Data Presentations from the ULTIMATE I & II Phase 3 Trials of Ublituximab in Multiple Sclerosis to be Presented at the Americas Committee for Treatment and Research in Multiple Sclerosis Annual Forum
Published: 2022-02-15 (Crawled : 13:30) - biospace.com/
TGTX | $14.25 1.06% 1.05% 3.2M

Health Technology

| 41.28% | O: 2.51% H: 8.21% C: 6.84%
america multiple sclerosis treatment als trials research trial therapeutics presentation sclerosis phase 3

InMed Pharmaceuticals Strengthens its Commercial Leadership Team with the Appointment of Vice President of Sales and Marketing for BayMedica
Published: 2022-02-15 (Crawled : 13:30) - biospace.com/
INM 4 | $0.279 -0.32% -0.32% 89K

Health Technology

| -75.44% | O: 0.0% H: 4.39% C: 1.75%
sales als commercialization

Hepion Pharmaceuticals Appoints World-Renowned Hepatologist, Dr. Eddie C. Cheung, to Lead the Company’s Strategic Medical Affairs in Asia
Published: 2022-02-15 (Crawled : 13:00) - hepionpharma.com
HEPA | $1.47 4.26% 4.08% 71K

Health Technology

| 41.0% | O: 1.0% H: 5.94% C: 0.99%
als air

Zynerba Pharmaceuticals Announces Planned Retirement of Suzanne Hanlon and Appoints Albert P. Parker as Chief Legal Officer
Published: 2022-02-15 (Crawled : 12:00) - zynerba.com
ZYNE | $1.3 3.08% 860K

Health Technology

| -51.85% | O: 0.74% H: 4.04% C: 4.04%
OCX | News | $2.5 -0.4% -0.4% 23K

Health Technology

| 61.94% | O: 0.65% H: 6.41% C: 4.49%
als ces

Agrochemicals Market in Canada Records a CAGR of 4.45% by 2026| Technavio
Published: 2022-02-15 (Crawled : 12:00) - prnewswire.com
NTR | $52.27 -0.06% -0.03% 1.4M

Process Industries